On the stock market since 2004, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 10% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades below its recent peak — about 9% off the top. A pullback, not a collapse.
Sales run at $6.1M a year. A small number, but proof the product has real buyers.
It pays out $1.20 per share each year — regular cash for whoever holds the stock.
A loss of $13.2M against $6.1M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, RSRFX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RSRFX is a high-risk stock — not yet profitable, and its future rides on its product catching on.